Atrayee Bhattacharya Dana-Farber Cancer Institute Biography Publications Institution JoVE Articles Atrayee Bhattacharya has not added a biography. If you are Atrayee Bhattacharya and would like to personalize this page please email our Author Liaison for assistance. Publications Addiction of Merkel Cell Carcinoma to MUC1-C Identifies a Potential New Target for Treatment Oncogene. Jun, 2022 | Pubmed ID: 35688945 Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer Cancers. May, 2022 | Pubmed ID: 35681561 DEPENDENCE ON THE MUC1-C ONCOPROTEIN IN CLASSIC, VARIANT AND NON-NEUROENDOCRINE SMALL CELL LUNG CANCER Molecular Cancer Research : MCR. May, 2022 | Pubmed ID: 35612556 MUC1-C Integrates Type II Interferon and Chromatin Remodeling Pathways in Immunosuppression of Prostate Cancer Oncoimmunology. 2022 | Pubmed ID: 35127252 MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells Molecular Cancer Research : MCR. 04, 2022 | Pubmed ID: 35022313 MUC1-C Dictates Neuroendocrine Lineage Specification in Pancreatic Ductal Adenocarcinomas Carcinogenesis. 02, 2022 | Pubmed ID: 34657147 Role of Flavonoids As Epigenetic Modulators in Cancer Prevention and Therapy Frontiers in Genetics. 2021 | Pubmed ID: 34858475 MUC1-C Activates the PBAF Chromatin Remodeling Complex in Integrating Redox Balance with Progression of Human Prostate Cancer Stem Cells Oncogene. 07, 2021 | Pubmed ID: 34163028 MUC1-C Integrates Activation of the IFN-γ Pathway with Suppression of the Tumor Immune Microenvironment in Triple-negative Breast Cancer Journal for Immunotherapy of Cancer. 01, 2021 | Pubmed ID: 33495298 MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells Cancer Research. 02, 2021 | Pubmed ID: 33323379 がんエピジェネティクス研究のためのATAC-Seq最適化 Mikhala Cooper*1, Atrayee Ray*1, Atrayee Bhattacharya2, Archana Dhasarathy1, Motoki Takaku1 1University of North Dakota School of Medicine and Health Sciences, 2Dana-Farber Cancer Institute JoVE 64242 Cancer Research
がんエピジェネティクス研究のためのATAC-Seq最適化 Mikhala Cooper*1, Atrayee Ray*1, Atrayee Bhattacharya2, Archana Dhasarathy1, Motoki Takaku1 1University of North Dakota School of Medicine and Health Sciences, 2Dana-Farber Cancer Institute JoVE 64242 Cancer Research